Medicine

Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer’s disease

T. Porter, V. Villemagne, G. Savage, Lidija Milicic, Y. Lim, P. Maruff, C. Masters, D. Ames, A. Bush, R. Martins, S. Rainey-Smith, C. Rowe, K. Taddei, D. Groth, G. Verdile, S. Burnham, S. Laws

2018.3.1Personalized Medicine in Psychiatry

DOI: 10.1016/j.pmip.2018.03.001

tlooto Summary

The defined Cognitive Gene Risk Profile has potential utility in participant selection/stratification for preclinical AD trials that incorporate Aβ-amyloid and where decline in cognition is essential to determine therapeutic effectiveness.

Abstract

Abstract is not available.

Citation format

PORTER, T., et al. Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic alzheimer’s disease. Personalized Medicine in Psychiatry, 2018, 7: 14–20.